Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RITUXIMAB-ABBS vs ROFECOXIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RITUXIMAB-ABBS vs ROFECOXIB: Safety Overview

Metric RITUXIMAB-ABBS ROFECOXIB
Total FAERS Reports 4,347 1,238
Deaths Reported 432 56
Death Rate 9.9% 4.5%
Hospitalizations 1,087 176
Average Patient Age 53.5 yrs 63.1 yrs
% Female Patients 74.2% 77.9%
FDA Approval Date N/A Feb 25, 2000
Marketing Status Prescription Discontinued